- Texas oral surgery practice opens 2 locations
- Intermountain cuts charting time 27% with AI assistant
- How 3 insurers are trying to tighten E/M billing oversight
- How 3 insurers are trying to tighten E/M billing oversight
- Texas orthodontics practices merge
- 73% of VA healthcare roles cut were recently filled: New York Times
- Network Health, backed by Cost Plus partnership, posts another year of record Medicare Advantage growth
- Network Health, backed by Cost Plus partnership, posts another year of record Medicare Advantage growth
- Children’s Health taps chief investment officer
- Appeals court could revive cardiologist’s anti-DEI retaliation lawsuit
- Mistrial declared in Virginia unlicensed dentistry case
- GI cancers to double by 2050: Report
- Private equity’s growing influence in healthcare — 6 recent deals
- Beth Israel Lahey Health CEO to step down next year
- 10 health systems named ‘exceptional workplaces’: Gallup
- Allegheny Health Network taps UH exec as chief nurse
- What It Takes to Deploy AI at Scale in Dentistry—and Why It Matters
- California system moves to delay layoffs
- California system moves to delay layoffs
- Why Prisma Health is betting big on outpatient expansion
- Anesthesia reimbursement decline over the last 5 years
- Federal resolution introduced to back fluoride use
- Salt Dental Partners expands in 3 states
- Cardiology and private equity in 2026: 5 notes
- UPMC gifted $1.25M to support care in North Central Pennsylvania
- NYC Health + Hospitals advances behavioral health strategy: 4 things to know
- Opening Remarks at Private Markets Roundtable
- 2 ASC consulting firms partner on united platform
- Strategic Radiology adds 14-physician practice
- 50 anesthesiology departments ranked by NIH funding
- Rhode Island lawmaker pushes for creation of new dental school: 6 notes
- CMS releases toolkit for children’s behavioral health services
- Qventus Launches Care Gap and Coding Automation Suite to Improve Patient Care and Reimbursement Revenue
- $32M deal closes on Boston-area medical center
- Dental therapist bill fails in Florida Senate
- ECU Health opens 2 gastroenterology clinics following practice acquisition
- Straine Dental Management adds 6th Texas practice
- Newport Healthcare taps chief growth and experience officer
- Independent autism research committee forms amid concerns over federal panel
- 12 health systems seeking revenue cycle vice presidents
- CommonSpirit eyes ASC growth to diversify portfolio
- From -2.6% to 10.7%: How 12 academic systems’ margins compare
- Remarks at Financial Stability Oversight Council Artificial Intelligence Innovation Series Roundtable on Strategy and Governance Principles
- Collegium enrolls Paris Hilton in Jornay PM push encouraging ADHD community to 'Embrace Your Sparkle'
- Review of U.S. Measles Elimination Status Delayed Until November
- Your Furry Roommate May Be Affecting The Air You Breathe
- BioDuro enters Taiwan joint venture, adding commercial API plant to production network
- FDA answers Vanda's yearslong call for public hearing on unsuccessful jet lag approval bid
- Beth Israel Lahey Health back in the black in Q1
- About 81,000 Baby Monitors Recalled Over Possible Fire Risk
- Armed with funding and an acquisition, Procode AI launches AI-powered RCM for surgical billing
- Charities merge to form nation's 'most comprehensive' patient assistance nonprofit
- Two Days of Oatmeal May Lower Cholesterol, Study Finds
- Bayer looking at another year of 'resilience' before growth kicks in behind Nubeqa, Kerendia
- Colorectal Cancer Rates Shifting to Younger Groups as Rectal Cancer Rates Spike
- Brain Chemical Provides A 'Pep In Your Step,' Experiment Shows
- Lithium Might Slow Brain Decline Among Seniors, Pilot Study Shows
- Exercise Boosts Quality of Life During Breast Cancer Chemotherapy
- Early Sports Specialization Linked To Increased Injury Risk
- More Kids, Teens Injured In E-Bike Wrecks, Study Finds
- Novo lands another FDA untitled letter, this time for Apple-inspired Ozempic ad
- Moderna fronts $950M to settle yearslong COVID patent litigation with Genevant, Arbutus
- Despite Their Successes, Some Mobile Crisis Response Teams Are in Crisis
- Lawmakers, Health Groups Resist Their States’ Rural Health Fund Plans
- Healthcare’s mixed Q4, plus insights from the Lake Nona Impact Forum
- Danish agency NoA Health names new CEO to drive global expansion
- Sanofi strikes $1.5B global licensing deal for Sino Biopharm's first-in-class JAK/ROCK asset
- Bassett Healthcare Network appoints division chief of dental services
- Aetna fined $550K for mental health parity violations
- Why CommonSpirit is exiting Conifer
- California provider opens teen mental health center
- Inside Huntsman’s hybrid model boosting social worker capacity sixfold
- FDA ramps up crackdown on GLP-1 drug compounding with fresh batch of 30 warning letters
- FDA ramps up crackdown on GLP-1 drug compounding with fresh batch of 30 warning letters
- HCA Healthcare says all-time high inpatient occupancy, ACA exchange attrition won't spoil 2026 volume growth
- Maryland awards $1.6M for substance use disorder, peer recovery workforce expansion
- Pfizer CEO Albert Bourla on FDA official Vinay Prasad: 'We have a problem with the leadership of CBER'
- Papa rolls out new program for insurers called Papa Plus
- Ireland’s biopharma appeal holds up amid unsteady geopolitical backdrop, US investment blitz
- San Diego provider opens 32-bed residential mental health facility
- AI Therapist? It Falls Short, a New Study Warns
- Mental health providers subject to ban on youth ‘transition’ procedures: Texas attorney general
- Grow Therapy scores $150M to build out enterprise partnerships with docs, employers
- Rising Stars: Boehringer’s Chris Kraemer on the power of patient impact
- Nearly 20 States Scale Back HIV Medication Programs
- BBQ Sauce Recall Issued Nationwide Due To Incorrect Label
- FDA Recalls More Than 651,000 Jugs of Water Over Sanitation Concerns
- Listen to the Latest ‘KFF Health News Minute’
- Hasta los pacientes se sorprenden por los precios que sus aseguradoras están dispuestas a pagar, un costo que al final pagamos todos
- Patients with multiple chronic diseases are a looming threat to health systems' financials: Vizient
- Guardant picks Patrick Dempsey for colorectal cancer blood test awareness
- Breast Cancer Cases, Deaths Expected To Rise Worldwide
- Collagen Supplements Good For Skin, Arthritis, Evidence Review Concludes
- Illicit Adderall Use Places Stress On The Heart, Study Shows
- A-Fib Drug, Diltiazem, Could Interact With Blood Thinners, Increase Risk Of Dangerous Bleeding
- How to Get Ready For Daylight Saving Time
- Effective Sunscreen Protection Can Cost $40 A Year
- Longtime Cigna CEO David Cordani to retire, Brian Evanko tapped as successor
- Acadia, undaunted by recent EU rejection, seeks CHMP re-examination of Rett syndrome med Daybue
- FDA’s CRLs reveal critical errors in AstraZeneca’s Saphnelo data, efficacy doubts for GSK’s Exdensur
- Federal Aid for Lead Cleanup Is Receding. That’s a Problem for Cash-Strapped Cities.
- Even Patients Are Shocked by the Prices Their Insurers Will Pay — And It Costs All of Us
- Readers Lean On Congress To Solve Crises in Research and Rehab
- Disc lays off 20% of employees to steady ship after FDA rejection of rare disease drug
- Novo plugs $500M into Ireland plant to produce Wegovy pill for markets outside US
- Esperion pays $75M-plus to acquire Corstasis and newly approved Enbumyst
- In 1 state, large hospitals dominate 340B's net savings
- HHS bans Claude AI tool as Trump seeks full government blacklisting of Anthropic
- Report: Most states investing in value-based care with Rural Health Transformation Program
- U.S. Tops 1,100 Measles Cases This Year as Outbreaks Grow
- FDA To Offer Cash Bonuses for Faster Drug Reviews
- 'One2PrEP': Gilead's 1st Yeztugo DTC ad reimagines hit song to highlight biannual dosing
- GLP-1s support heart attack recovery in rodents by relaxing tight blood vessels
- Former Optum CEO Heather Cianfrocco to depart UnitedHealth Group
- New Drug, Acoziborole, Could Boost Efforts to Wipe Out Sleeping Sickness
- Chocolate Male Supplement Recalled Over Hidden Erectile Dysfunction Drug
- Amid unfolding Middle East war, pharma giants keep close eye on employee safety, supply chains
- CMS set to suspend enrollment in Elevance Health's Medicare Advantage plans
- Providers urge Education Department to reconsider which jobs face stiffer student loan caps
- Kennedy adds 2 new members to CDC’s vaccine panel ahead of delayed meeting
- Kennedy adds 2 new members to CDC’s vaccine panel ahead of delayed meeting
- Urban Traffic Noise Disrupts Sleep, Affects Heart Health After One Night
- Hormone Therapy Might Be Unnecessary For Some Prostate Cancer Patients
- Benzodiazepine Use Down In U.S., But OD Risk Remains, Study Says
- GLP-1 Drugs Might Ease Chronic Migraine, Study Says
- Blood Test Reveals Alcohol-Related Liver Disease
- Telemedicine Visits Cost Five Times Less Than In-Clinic Care
- Families Defend Disability Services Amid Medicaid Cuts
- Medicaid Is Paying for More Dental Care. GOP Cuts Threaten To Reverse the Trend.
- Quest Diagnostics launches Google-powered AI chatbot to help patients understand lab results
- Tennr takes aim at phone call bottlenecks as it builds out automation for patient referral process
- DoseSpot, Arrive Health merge to combine prescribing tools with pharmacy, medical benefit data
- Why Digital Tool are Needed to Cope with Increasing Pressures in MedTech Innovation
- Why Digital Tool are Needed to Cope with Increasing Pressures in MedTech Innovation
- Electronics Pollution Pose Added Threat to Endangered Dolphins, Porpoises
- Flea And Tick Pills May Pose Environmental Risks, Study Finds
- ICE, ALS, Addiction Medicine, and Robotic Ultrasounds: Journalists Sound Off on All That and More
- Statement on the Adoption of Final Rules Under the Holding Foreign Insiders Accountable Act
- Statement on Final Rules for the Holding Foreign Insiders Accountable Act
- State Medicaid budgets to weather $664B reduction through 2034 due to OBBBA: RAND
- Clover Health CEO said company sees opportunity in complex MA environment
- Walgreens debuts virtual weight management clinic with access to GLP-1 meds
- New Obamacare Rules Could Raise Deductibles to $31K For Families
- Study Suggests One Common Amino Acid May Affect How Long Men Live
- Walmart Great Value Cottage Cheese Recalled Over Pasteurization Issue
- Chris Bosh Says He’s 'Lucky To Be Alive' After Sudden Health Scare
- How the Brain Learns to Have Seizures During Sleep
- Blood Test Can Predict Short-Term Survival Among Seniors
- Why Turning 19 Spikes Medicaid Loss for Millions
- Crash Course Might Speed Brain Stimulation Treatment For Depression, Study Suggests
Federal health policy news & impact
1
Posts
1
Users
0
Reactions
407
Views
Topic starter
August 31, 2023 4:57 pm
Morning Brew today outed HHS as an advocate for the marijuana industry. They may deny it, but methinks the stockmarket response tells the truth of the matter.
Prove me wrong!
Health officials urge reclassification of marijuana as a lower-risk drug. Leaders at the Department of Health and Human Services urged the Drug Enforcement Administration to ease restrictions on marijuana in a letter viewed by Bloomberg. Weed is currently considered a Schedule I substance under the Controlled Substances Act, putting it in the same category as LSD and heroin, but the letter said it should be changed to a Schedule III substance, like pain medications and testosterone. This would not legalize the drug, as many states have done, but it would bring down some of the barriers the cannabis industry is facing, such as being barred from banks, so stocks in the industry rose on the news.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.
Sponsors
Friends of MHF
Kirsten DeVries
Tom & Karen Nunheimer
Steve Ahonen
Ron & Faith Bosserman
Marlin & Kathy Klumpp
Sign Up for MHF Insights to keep up on the latest in Michigan Health Policy
